Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 617 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Talon Therapeutics reports Q3 net income

Loss from operations for third quarter of 2012 was $7.39m compared to loss from operations of $3.35m for the third quarter of 2011. The company reported a net

EpiCept Q3 net loss narrows

Loss from operations for the third quarter of 2012 was $1.08m compared to $4.37m operating loss in the previous year. The company reported a net loss of $1.70m,